[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350318-105":3,"detail-sidebar-cat-0-en-105":80,"doc-detail-350318-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","tmem184a-promotes-progression-and-drug-resistance-in-colorectal-cancer-a-bioinformatics-and-clinical-study","TMEM184A promotes progression and drug resistance in colorectal cancer - A bioinformatics and clinical study","","TMEM184A-related cellular origins and molecular mechanisms of therapeutic resistance in colorectal cancer remain unclear. This bioinformatics and clinical study integrates single-cell and spatial transcriptomics, molecular docking, and multi-cohort public databases to define TMEM184A-driven epithelial drug-resistance programs, then validates clinical relevance using pathological paraffin samples. Analyses include cell–cell communication, CNV heterogeneity, pseudotime, immune infiltration, and tissue microarray immunohistochemistry. TMEM184A is linked to lipid metabolism, rectal enrichment, lymph node metastasis, and poor prognosis, and shows strong binding to lapatinib and EGFR tyrosine kinase inhibitors.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/tmem184a-promotes-progression-and-drug-resistance-in-colorectal-cancer-a-bioinformatics-and-clinical-study/350318/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/tmem184a-promotes-progression-and-drug-resistance-in-colorectal-cancer-a-bioinformatics-and-clinical-study/350318.png","ImageObject",300,407,{"name":42,"@type":43},"Terk","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":30},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"What data and methods were integrated to uncover TMEM184A-associated drug resistance?","Question",{"text":62,"@type":63},"The study integrates single-cell transcriptomics, spatial transcriptomics, molecular docking, and multi-cohort public databases, and validates findings using clinical pathological paraffin samples and tissue microarray immunohistochemistry.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"Which biological pathways are enriched in the epithelial drug-resistance–associated cell subset?",{"text":67,"@type":63},"The resistant epithelial subset shows enrichment of interferon, TNF-α/NF-κB, TGF-β, hypoxia, and p53 signaling pathways.",{"name":69,"@type":60,"acceptedAnswer":70},"How does TMEM184A relate to prognosis and the immune microenvironment in colorectal cancer?",{"text":71,"@type":63},"High TMEM184A expression is associated with poor prognosis, correlates with regulatory T cell (Treg) infiltration, and is linked to the “low immune-low stroma” microenvironment.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},350318,1790708101,{"code":4,"msg":81,"data":82},"success",[83,87,91,95,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":84,"show_sort_weight":85,"slug":86},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Exam",70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":81,"data":131},{"doc_id":78,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":30,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099525198933,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nTMEM184A promotes progression and drug resistance in colorectal cancer: a bioinformatics and clinical study  \nXueliang Bai1,2, Zhongyuan Bai4, Peng Bu2, Ruijiang Liu1, Guohai Zhao2, Wei Cui2, Yongping Cui3􀀍 & Yanfeng Xi2􀀍  \nThe cellular origin and molecular mechanisms underlying therapeutic resistance in colorectal cancer remain largely unclear.This study integrates single-cell transcriptomics, spatial transcriptomics, molecular docking, and multi-cohort public databases to systematically elucidate the epithelial celldriven drug resistance mechanism, and combines clinical pathological paraffin samples to evaluate the clinical significance and prognosis of the key protein TMEM184A. Integrated single-cell datasets underwent quality control and PCA/UMAP clustering, followed by annotation verified through spatial transcriptomic mapping. CellChat, CopyKat, inferCNV, Monocle3 and AUCell analyses were applied to assess cell–cell communication, CNV heterogeneity and pseudotime differentiation. Integrate the TCGA, GEO data, as well as the drug sensitivity data from GSCA andCTR-DB 2.0, and combine with the AutoDock molecular docking results to explore the correlation between genes and prognosis, as well as immune infiltration, and their pharmacological effects. Use the tissue microarray technique to detect the protein expression ofTMEM184A in cancer tissues and adjacent tissues, and analyze its association with clinical pathological features and patient prognosis. The study identified a subset of epithelial cells associated with drug resistance, characterized by the enrichment of interferon, TNF-α/NF-κB, TGF-β, hypoxia, and p53 signaling pathways.By combining machine learning and clinical prognosis analysis, the key drug-resistant driving geneTMEM184A was finally determined. The genes related toTMEM184A were significantly enriched in the lipid metabolism pathway. Moreover, TMEM184A were highly expressed in microsatellite stable colorectal cancer, positively correlated with regulatory T cell (Treg) infiltration, and associated with the “low immune-low stroma” microenvironment. The analysis of immunohistochemical staining on tissue microarrays showed that the high expression ofTMEM184A protein was related to lymph node metastasis, and was more prevalent in the rectal region. Additionally, the high expression ofTMEM184A was associated with poor prognosis in patients. Drug sensitivity and molecular docking analysis indicated that TMEM184A had strong binding affinity with lapatinib and various EGFR tyrosine kinase inhibitors. TMEM184A promotes the occurrence of drug resistance in colorectal cancer by regulating lipid metabolism. The high expression of this protein in the rectum is more common and is associated with lymph node metastasis and poor prognosis inpatients with colorectal cancer. This study provides a theoretical basis forTMEM184A to be used as a prognostic marker and a therapeutic target for drug resistance in colorectal cancer.  \nKeywords Colorectal cancer, TMEM184A, Drug resistance, Clinical Significance  \nAbbreviations  \nCRC Colorectal cancer  \nAUCell Area Under the Curve enrichment scoring  \n1School of Basic Medicine, Shanxi Medical University, Taiyuan 030001, Shanxi, China. 2Cancer Hospital Affiliated to Shanxi Medical University, Department of Pathology, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Taiyuan 030013, Shanxi, China. 3Department of Pathology, Basic Medical Sciences Center, Key Laboratory of Cellular Physiology of Shanxi Medical University, Taiyuan 030013, Shanxi, China. 4Shanxi Medical University, Taiyuan 030001, Shanxi, China. 􀀍 email: [cuiyp@sxmu.edu.cn](cuiyp@sxmu.edu.cn); [xiyanfeng1998@163.com](xiyanfeng1998@163.com)  \n[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nCAF Cancer-associated fibroblast  \nCNV Copy-number variation  \nEGFR E","cbCaik7AetqtO5nA","https://ap.wps.com/l/cbCaik7AetqtO5nA","pdf",8378841,17,"English","# Background\n## Clinical challenge: colorectal cancer drug resistance\n## Mechanistic basis of resistance and immune suppression\n# Study design and methods\n## Multi-omics integration and computational analyses\n## Clinical validation with tissue microarrays\n# Results\n## Epithelial cell subset linked to drug resistance\n## TMEM184A expression, immune microenvironment, and prognosis\n## Drug sensitivity and molecular docking\n# Conclusions","[{\"question\":\"What data and methods were integrated to uncover TMEM184A-associated drug resistance?\",\"answer\":\"The study integrates single-cell transcriptomics, spatial transcriptomics, molecular docking, and multi-cohort public databases, and validates findings using clinical pathological paraffin samples and tissue microarray immunohistochemistry.\"},{\"question\":\"Which biological pathways are enriched in the epithelial drug-resistance–associated cell subset?\",\"answer\":\"The resistant epithelial subset shows enrichment of interferon, TNF-α/NF-κB, TGF-β, hypoxia, and p53 signaling pathways.\"},{\"question\":\"How does TMEM184A relate to prognosis and the immune microenvironment in colorectal cancer?\",\"answer\":\"High TMEM184A expression is associated with poor prognosis, correlates with regulatory T cell (Treg) infiltration, and is linked to the “low immune-low stroma” microenvironment.\"}]","TMEM184A promotes progression and drug resistance in colorectal cancer - A bioinformatics and clinical study | PDF",1790088418,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/33e0fd1b7375eb0ca8d7cd9001f3110e.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3c2469d400ec925ad0fa1541215759c7.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d527dc64fa4d558a5f7058dc05fa411b.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5b30879dc79e01d33b6684afd80cfb99.webp",980,1287]